Daniel Mullins, MD
Colon & Rectal Surgery · Bloomfield, CTNPI 1205063849
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Intuitive Surgical at 49.1% of the total. Reporting peaked in 2019 at $1,342 and has fallen 75.9% since, to $323 in 2025.
Across 69 payments — averaging $39.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Takeda Pharmaceuticals U.S.A., Inc.$331
- AbbVie$231
- Bristol Myers Squibb$162
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$124
- Johnson & Johnson$109
- plus $433 from 13 others
What the payments were for
- Travel & lodging$1907%
- Food & beverage$1,54256%
- Education$1,00037%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $1,343 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $331 |
| AbbVie(2 entities) | 12 | $231 |
| Bristol Myers Squibb | 9 | $162 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $124 |
| Johnson & Johnson(2 entities) | 6 | $109 |
| THD America, Inc. | 1 | $105 |
| Shire North American Group Inc | 3 | $46 |
| Intercept Pharmaceuticals, Inc. | 2 | $43 |
| Celltrion USA Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $29 |
| KCI USA, Inc. | 1 | $29 |
| Covidien LP | 1 | $27 |
| Stryker | 1 | $26 |
| Exact Sciences | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
| Axonics, Inc. | 1 | $19 |
| Masimo Corporation | 1 | $17 |
| Davol Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,315
How this compares
$2,732 in reported general payments places this provider in the 65th percentile of 48 colon & rectal surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 13 | $601,720 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 24 | $4,116 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 55 | $3,357 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $298 |
| Neomycin Sulfate | 38 | $188 |
| Dicyclomine Hcl | 17 | $156 |
| Metronidazole | 43 | $80 |
| Oxycodone Hcl | 13 | $62 |
| Hydrocortisone | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $331 | $601,72013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 48 colon & rectal surgery providers in Connecticut.
Other colon & rectal surgery in Bloomfield
- Rachel ScottBloomfield$5K
- Robert LewisBloomfield$4K
- Amanda AyersBloomfield$3K
- Andrew RaissisBloomfield$1K
- Jonathan ChangBloomfield$1K
- David WaltersBloomfield$500
- Saumitra BanerjeeBloomfield$205
- Vanessa BarattaBloomfield$76
- John MonsonDanbury$182K
- George YavorekNew Haven$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.